Transsynaptic activation of tyrosine hydroxylase (TH) within sympathetic autonomic ganglia is a widely recognized event and is implicated in restoration of synaptic stores of catecholamines following depolarization. The immediate effect is an increase in activity of existing pools of TH but, ultimately, higher levels of the enzyme are induced through increases in TH mRNA levels and activation of the gene (Kilboume et al., 1992) (McKeon and Zigmond, 1993) (WesselsReiker et al., 199 1) . Although cholinergic transmission may be the principal factor involved in this regulation, a role for other noncholinergic neuromodulators within preganglionic nerve ter-minals in controlling postganglionic sympathetic nerve function has been implicated for some time. Initial studies demonstrated electrophysiological responses in frog sympathetic ganglia that could not be accounted for by cholinergic transmission (Nishi and Koketsu, 1968) . However, the existence of an analogous response in mammalian sympathetic ganglia was initially suggested by Chen (197 1) and was subsequently demonstrated electrophysiologically (Ashe and Libet, 198 1) . A specific role for the regulatory peptide, vasoactive intestinal peptide (VIP), a 28 amino acid peptide (Said, 1982) has been suggested by its effect on the accumulation of CAMP in rat sympathetic ganglia (Volle and Patterson, 1982; Ip et al., 1985) and by its stimulation of tyrosine hydroxylase activity in rat superior cervical ganglia (Ip et al., 1982 (Ip et al., , 1985 Malhotra et al., 1987) . This peptide has been localized to nerve terminals within both bovine adrenal medullary tissue (Yoshikawa et al., 1990) and rat superior cervical ganglia (Sasek and Zigmond, 1989) . Furthermore, VIP immunoreactivity (VIP-IR) has been demonstrated in nerve cell bodies of the intermediolateral column of the spinal cord (Krukoff, 1986; Baldwin et al., 1991) . Infusion of VIP causes release of catecholamines from adrenal medullary tissues (Malhotra et al., 1987 (Malhotra et al., , 1988 Misbahuddin et al., 1988) . VIP activates adenylate cyclase and through this pathway increases TH activity (Roskoski et al., 1989) and TH mRNA levels (Wessels-Reiker et al., 1991) .
Subsets of postganglionic sympathetic nerves and adrenal medullary cells (Vamdell et al., 1984) contain neuropeptide Y (NPY) (Tatemoto, 1982; Colmers and Wahlestedt, 1993) , a 36 amino acid regulatory peptide, where it coexists with catecholamines and is released during nerve stimulation Potter, 1988) . Studies on the regulation of the NPY gene have concentrated principally on the role of NGF, phorbol esters, and CAMP (Sabol and Higuchi, 1990; Balbi and Allen, 1994) . Transsynaptic regulation of NPY mRNA levels have been demonstrated (Schalling et al., 1989; Hanze et al., 1991) , and it has been suggested that the NPY gene may be regulated, in part, by noncholinergic factors (Schalling et al., 199 1) . However, little is known of the role of peptide neurotransmitters localized in preganglionic nerve terminals in regulating NPY gene expression. In view of the proposed role of VIP in transsynaptic regulation of the enzyme involved in catecholamine biosynthesis, we have studied the effect of this peptide neurotransmitter on transcription of the NPY gene using PC12 cells (Greene and Tischler, 1976) Cyclase Activating Peptide (PACAP) and its fragments from Peninsula Laboratories. NGF and the peptides were dissolved in DMEM, aliquoted, and stored at -70°C until use. PC12 cell cultures, Cells were grown in polystyrene tissue culture dishes (Nunc, GIBCO), coated with air dried rat tail collagen (Sigma), in Dulbecco's Modified Eagle's Medium (DMEM; GIBCO) supplemented with 10% heat-inactivated horse serum (GIBCO), 5% fetal calf serum (GIBCO). 2 mM alutamine (Siama). 100 me/ml strentomvcin (GIBCO), and ib0 U/ml-penicillin (GfBCo).
---Chloramphenicolacetyl transferase (CAT) assay. A fragment of DNA (-700 bp) of the 5' flanking region of the NPY gene was obtained by polymerase chain reaction (PCR). The downstream primer (3') was located in the middle of exon 1, thus including the cap site of the NPY gene but avoiding the first initiation codon (Larhammar et al., 1987) . The upstream (5') primer was designed to start at -674 relative to the trans&ption start site. The PCR product was first subcloned into the HincII site in the nolvlinker reaion of the vector DGEM 3U+) (Promega), in order to &c&s suitabg cloning sites at both ends of'tge 'PCR product, and then subcloned into the PstI and XbaI sites in the polylinker of pCAT basic vector (Promega). The sequence of this construct was verified and is referred to as NPY-CAT (Balbi and Allen. 1994) .
DNA was transfected into PC12 cells (70% confluent plate) using a standard calcium phosphate precipitation method (Kingston, 1987) . All experimental conditions were performed in duplicate. The following day, the various compounds described in the results section were added to the incubation medium. In the case of the inhibitors, the cells were incubated with these for 60 minutes before any subsequent additions. After incubation for a further 48 hr, cells from each plate were harvested in phosphate buffered saline (PBS). After pelleting, the cells were lysed by addition of 100 ~1 of 250 mM Tris (pH 7.8) and three freeze-thaw cycles. Endogenous de-acetylase activity was inactivated by heating to 65°C for 10 min. The amount of total protein in each sample was determined photometrically using the Bradford Bio-Rad procedure. Aliquots of each extract representing equal amounts of protein were then assayed for CAT activity by measuring the acetylation of W-labeled chloramphenicol (Amersham) in the presence of excess acetyl coenzyme A to act as acyl donor. Acetylated chloramphenicol and chloramphenicol were extracted in ice cold ethyl acetate and separated on thin layer chromatography plates using a solvent mix of 9: 1 chloroformmethanol.
The plates were exposed to x-ray film (Fuji RX) for 24 hr. For quantitation, the optical density of the bands on the film was measured using a Molecular Dynamics densitometer and the density of each band above background was calculated. 
Results
Transfection of PC1 2 cells with NPY-CAT resulted in measurable levels of CAT activity in cell extracts. No CAT activity was detected in nontransfected cell extracts or in cells transfected with the basic CAT vector (lacking the NPY promoter) (Balbi and Allen, 1994) . Addition of VIP (5 PM, Peninsula Laboratories) to PC12 cells transfected with the NPY-CAT fusion gene resulted in a marked increase in the measurable CAT activity compared to controls (Fig. 1A) . Pretreatment of PC12 cells with H-89, an inhibitor ofcAMP-dependent protein kinase (PKA) (10 PM; Calbiochem) ( Fig. 1.4 ) blocked the effect of VIP on induction of NPY gene transcription in a concentrationdependent fashion (Fig. IB) . H-89 specifically inhibits PKA with a K, of 48 nM, whereas its inhibition constant for PKC is 31.7 PM. Addition of a specific inhibitor of calcium/phospholipiddependent protein kinase (PKC), calphostin C (1 PM; Calbiochem) (Shimamoto et al., 1992) , reduced the effect of VIP on NPY-CAT to a small but reproducible extent (Fig. 1A) . Calphostin C is a highly specific inhibitor of PKC with a K, of 50 nM. Its inhibition constant for PKA is greater than 50 PM. The threshold concentration for VIP induction of NPY gene transcription was 5 nM. Increasing concentrations above this threshold resulted in progressively higher levels of CAT activity, indicating that the effect of VIP on the promoter region of the NPY gene was concentration dependent (Fig. 2) . The effect of VIP on the NPY gene was then compared to that of forskolin (20 PM; Sigma). Both VIP and forskolin increased CAT activity in cell extracts, and this increase was inhibited by 50% following preincubation of cells with 5 PM H-89. Preincubation with calphostin C resulted in a small but consistent decrease in the subsequent response of NPY-CAT to either VIP or forskolin (Fig. 3) .
Pituitary adenylate cyclase activating polypeptide is a 38 amino acid peptide which is a member of the secretin/glucagon/ VIP peptide family (Arimura, 1992) . Addition of PACAP to transfected PC 12 cells resulted in responses similar to the effect of VIP. However, the effect of PACAP was observed at considerably lower concentrations. Thus, the threshold concentration for PACAP to stimulate activity of the NPY-CAT fusion gene was 5 PM. Increasing concentrations of PACAP resulted in higher levels of CAT activity directed by the NPY gene, until a maximum response was reached at 5 nM (data not shown). Two fragments of PACAP, l-27 and 16-38, were tested for effect on NPY-CAT activity. The N-terminal fragment l-27 was found to have a positive effect although the threshold for this response was higher (50 PM) than for the full-length molecule (data not shown). The C-terminal fragment (16-38) had no effect on the NPY-CAT activity (Fig. 4) . Preincubating cells with H-89 completely blocked the response of NPY-CAT to both PACAP and its l-27 fragment (Fig. 4) .
Incubation of PC1 2 cells with VIP (5 PM) resulted in a marked change in their appearance, converting them over 2 d of incubation into cells that resemble neurons-the cells flatten and extend long, slender neurites with prominent growth cones (Fig.  5) . The response in terms of neurite extension was apparent within 6 hr of applying VIP. The ~threshold concentration of VIP required to produce the morphological response was higher than that required to alter NPY gene transcription. Thus, 500 nM VIP resulted in neurite extension whereas addition of 50 nM VIP caused virtually no response. Interestingly, preincubation of PC1 2 cells with H-89 did not alter the subsequent change in morphology induced by VIP. In parallel studies, the effect of various concentrations of H-89 on the morphological appearance induced by VIP (Fig. 5) were compared to that of induction of CAT activity under NPY promoter control (Fig. 1B) . The morphological effects of VIP could not be blocked by preincubation of PC12 cells with H-89 even at a concentration (30 KM)' which completely reversed the effect of VIP on the activity of the NPY-CAT fusion gene (Figs. lB, 5 ). Higher concentrations of H-89 killed PC1 2 cells. In view of the minor inhibition by calphostin C of VIP and forskolin stimulated activity of the NPY-CAT fusion gene, the effect of this inhibitor alone and in combination with H-89 on VIP induced differentiation was assessed. No inhibition of differentiation was observed. Addition of PACAP (5 nM) or PACAP (5 nM) resulted in a similar The morphological change induced by VIP appeared distinct from that produced by NGF (Fig. 6) induced by NGF appeared more stubby than those following incubation with VIP at equivalent time points. Unlike the NGF induced changes in morphology, only a subpopulation of the PC1 2 cells (approximately half of the cells) underwent this change following addition of VIP. Addition of NGF and VIP simultaneously to the PC12 cells caused the cells to adopt some of the characteristics of both differentiation agents (Fig. 60) . Thus, the appearance of the neurites was more characteristic of that observed for VIP alone, as these appeared long and slender with bulbous growth cones. However, the cell bodies appeared much enlarged compared to VIP alone, and were more in keeping with the changes observed after NGF. Interestingly, although nearly all the cells apparently responded to NGF alone in terms of differentiation, when NGF and VIP were added simultaneously, only half the cells appeared to differentiate into neuronal phenotype.
Discussion
In this report, we examine the role of VIP in regulating transcriptional activity of the NPY gene, in particular the influence of various second messenger systems. Previous studies have shown that VIP induces expression of the gene for TH in PC 12 cells (Wessels-Reikeretal, 199 1). A role for this peptide in transsynaptic regulation of the TH activity has been implied by the findings that VIP-IR is present in cells of the intemediolateral column and in nerve terminals of postganglionic sympathetic nerves and adrenal medulla (Krukoff, 1986; Sasek and Zigmond, 1989; Yoshikawa et al., 1990) . Transsynaptic activation of TH is now well recognized and some studies have indicated that similar processes may regulate NPY gene activity (Schalling et al., 1989; Hanze et al., 199 1) . However, although noncholinergic factors have been implicated in this regulation (Schalling et al., 1991) , little is known of the nature of these agents mediating these responses. Our findings here demonstrate that VIP is capable of inducing NPY gene expression and that the concentration threshold required to achieve this response is equivalent to previous studies of TH mRNA induction (Wessels-Reiker et al., 1991) . Our study has shown that the related peptide PACAP also stimulates NPY gene expression. PACAP (Arimura, 1992 ) is a 38 amino acid peptide originally isolated from the bovine pituitary. The N-terminal 28 residues are similar in sequence to VIP, being 68% homologous. As the 28th amino acid of PACAP is a glycine residue followed by two basic amino acids, it has been suggested that PACAP is cleaved to yield PACAP27-amide. Our results indicate, first, that PACAP was considerably more potent than VIP in stimulating NPY gene transcription and, second, that activity resided in the N-terminal fragment of the peptide. The difference in threshold of response of VIP compared to PACAP strongly suggests that these effects are mediated through the presence of a receptor for PACAP on PC12 cells, and that VIP may be acting through this receptor by virtue of its similar sequence. Recently, high-affinity receptors for PACAP have been found in the rat adrenal medulla (Shivers et al., 199 1) and the cDNA encoding this receptor has been identified and characterized from a library constructed from adrenal mRNA (Morrow et al., 1993) . These findings raise the possibility that PACAP is the factor involved in transsynaptic activation of postganglionic sympathetic structures, although, as yet, there are no reports detailing the presence of PACAP in preganglionic structures. It is possible that the previously reported VIP-IR may represent cross-reactivity of antisera raised to VIP with the related peptide, PACAP. Both peptides may be present and active in preganglionic autonomic transmission as preliminary reports have shown that infusion of PACAP releases catecholamines from rat adrenal glands and PACAP-immunoreactivity can be measured in plasma during electrical stimulation of the splanchnic nerves (Wakade et al., 1992) .
Both VIP and PACAP appear to alter NPY gene transcription through the activation of PKA, as the responses were completely reversed by the addition of H-89, an inhibitor of CAMP-depen- dent protein kinase (PKA). The response could also be mimicked by addition of forskolin. Both VIP and PACAP are known to activate adenylate cyclase in other systems (Said, 1982; Arimura, 1992) . The response of the NPY gene occurs even in the absence of a CAMP response element (CRE) consensus sequence in the 5' flanking region of the gene. Examination of the gene sequences reveals two AP-2 sites (Balbi and Allen, 1994 ) that, in other systems, can mediate responses to CAMP (Roesler et al., 1988) . Specific deletion of these will be necessary to define the role of these AP-2 sites in controlling NPY gene transcription in response to CAMP. Calphostin C, a specific inhibitor of PKC, caused a small but consistent reduction in the increase in NPY gene transcription induced by both VIP and forskolin indicating that these peptides may also activate phospholipase C. Alternatively, it may indicate cross talk between the two kinase systems (Yoshimasa et al., 1987) .
A trophic role for VIP has been suggested by previous studies using cultured sympathetic neuroblasts (Pincus et al., 1990) . Our study has shown that PC 12 cells adopt a distinctive morphological appearance in response to both VIP and PACAP, thus providing further evidence for a trophic role for these peptides in the sympathetic nervous system. The pattern induced by VIP and PACAP appeared different to that following NGF, and was similar to that induced by either forskolin or dibutyryl CAMP. Thus, it seems likely that the action on morphological differentiation induced by VIP and PACAP is explicable by the activation of adenylate cyclase and it may not be necessary to postulate the existence of a separate "trophic" receptor, as has been proposed for angiotensin II (Bottari et al., 1993) . In keeping with this, VIP appears to exert its neurotrophic effect on rat sympathetic neuroblasts through CAMP (Pincus et al., 1990) . However, the effect on VIP and PACAP on morphological appearance is independent of PKA or PKC unlike their effect on NPY gene transcription. The precise mechanism of the VIP or PACAP induced morphological changes remains unclear in the absence of any dependence on phosphorylation mediated by PKA. CAMP has recently been shown to have a direct effect on the hyperpolarization-activated current in cardiac pacemaker cells, suggesting direct activation by CAMP of an ion channel (DiFrancesco and Tortora, 1991) . Similar channels have been described in some neurones (Bobker and Williams, 1989) , although it is not known whether, in these neurones, the channels are also capable of directly binding CAMP. Direct activation of ion fluxes by CAMP may mediate the change in morphological appearance through stimulation of proto-oncogenes Cm-ran, 1986, 1991) . In neuroblastoma cells, PACAP has been shown to increase cytosolic calcium through both release from intracellular stores and entry of external calcium (Delporte et al., 1992) . However, the dependence of this response on phosphorylation by PKA was not addressed. The proto-oncogene ras (Barbacid, 1987) , has been implicated in mediating neuronal differentiation (Borasio et al., 1989) (Bar-Sagi and Feramisco, 1985) but this protein has been associated more with the tyrosine kinase activated pathways of the growth factor receptors (Egan and Weinberg, 1993) . Recent studies have demonstrated that CAMP in some cell lines interferes with the ras pathway activated by tyrosine kinase receptors. However, the evidence indicates that this effect of CAMP is mediated by PKA phosphorylation of Raf-1 (Cook and McCormick, 1993) (Wu et al., 1993) . Thus, a similar cross talk mechanism cannot account for the findings of this study, where inhibitors of PKA had no effect on the morphological changes induced by VIP/PACAP. There remains the possibility that VIP/PACAP are mediating their effects on morphology through a separate signaling pathway, independent of PKA. A recent study using in vitro autoradiography has proposed that there are multiple VIP receptors in the developing mouse embryo, of which one is insensitive to GTP (Gressens et al., 1993) .
The change to a neuronal pattern of morphology observed in PC12 cells following the addition of VIP or PACAP suggests that these peptides may play an important trophic role in the CNS and PNS, in addition to the accepted neurotransmitter function of VIP in postganglionic parasympathetic nerves. VIP-IR has been demonstrated in the early developing brain and spinal cord (Maletti et al., 1980; Fuji et al., 1985) although levels of detectable immunoreactivity are low in embryonic tissues. However, high levels of VIP receptors are found in the CNS during development and in mouse embryo explants (Gressens et al., 1993) . The peptide has been shown to have profound effects on embryonic growth, in vitro (Gressens et al., 1993) and on sympathetic neuroblasts derived-from foetal rats of 15.5 d gestation (Pincus et al., 1990) indicating that the receptors are present on target tissue at the appropriate time in development. A number of additional studies have shown that VIP promotes neuronal survival in vitro (Brenneman et al., 1985; Gozes and Brenneman, 1993) and causes neurite extension of neurones from ventral spinal cord of embryonic rats (Iwasaki et al 1990) . Thus, it is possible that, within preganglionic sympathetic nerves, the trophic role of these peptides may be their primary action in the developing nervous system, whereas their regulation of sympathetic nerve function may occur later once the specialized environments are achieved by high steroid input to the adrenal medulla and the establishment of NGF dependence in the sympathetic nervous system.
